• Clinical Technology
  • Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Geriatrics
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Oncology
  • Nephrology
  • Neurology
  • Pulmonology

Recognizing and Diagnosing Atopic Dermatitis With Confidence

Opinion
Video

Panelist discusses how the atopic dermatitis treatment landscape has evolved with new non-steroidal topical therapies that can match the effectiveness of corticosteroids without their associated side effects and long-term risks.

Video content above is prompted by the following:

Eingun James Song, MD, FAAD, a dermatologist from Frontier Dermatology in Mill Creek, Washington, introduces a comprehensive discussion on atopic dermatitis topical treatments. As a specialist who focuses primarily on inflammatory skin conditions and has conducted clinical trials for atopic dermatitis therapies, Dr. Song brings both professional expertise and personal experience to the topic, noting that his entire family lives with atopic dermatitis. This presentation addresses the significant gap in topical treatment innovation that existed until recent years, when the dermatology field relied heavily on topical corticosteroids despite their long-term side effects and limitations.

The presentation focuses on the revolutionary advancement in non-steroidal topical therapies that have emerged in 2025, addressing the longstanding unmet need for effective alternatives to corticosteroids. Traditional treatment options were limited to topical corticosteroids, which remain effective but carry concerns about prolonged use, and older non-steroidal agents that often-caused significant burning and stinging while providing inferior efficacy. The introduction of several innovative non-steroidal topical therapies has transformed the treatment landscape, offering dermatologists and primary care providers powerful new tools for managing atopic dermatitis without the traditional drawbacks of steroid therapy.

Dr. Song establishes three primary objectives for the presentation: recognizing atopic dermatitis in its early, more treatable stages; understanding how to integrate new non-steroidal topical therapies into clinical practice; and fostering collaboration between dermatologists and primary care providers to ensure patients receive optimal treatment access. The interactive format encourages real-time questions and engagement, emphasizing that early recognition and treatment of mild to moderate atopic dermatitis represents the optimal therapeutic window for achieving the best patient outcomes and preventing disease progression.

Related Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.